ClinicalTrials.govpublic full text
Bintrafusp Alfa Program Rollover Study
lung cancer, cancer, solid tumors, tumor response, safety, efficacy, response evaluation criteria in solid tumors version 1.1 (recist1.1), programmed death ligand 1, survival follow-up, human transforming growth factor β (tgfβ) receptor ii, performance status, bintrafusp alfa
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 908980
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.